Easy To Use Patents Search & Patent Lawyer Directory

At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.

Searching:





Search by keyword, patent number, inventor, assignee, city or state:




Patent # Description
2018/0207181 REDUCING THE REPRODUCTIVE CAPACITY OF MAMMALS
Provided are compositions and methods for reducing the reproductive capacity of mammals. The compositions and methods involve the use and administration of (a)...
2018/0207180 METHODS FOR TREATING AND PREVENTING NOCICEPTIVE PAIN
Methods of treating a condition resulting in nociceptive pain are provided. The method includes the step of administering to a mammal a therapeutically...
2018/0207179 HALOGENATED SALICYLANILIDES FOR TREATING CLOSTRIDIUM INFECTIONS
The present invention relates to halogenated salicylanilides, or pharmaceutically acceptable salts or esters thereof, for use in the treatment of an infection...
2018/0207178 TOPICAL FORMULATIONS COMPRISING A STEROID
The application provides formulations for the topical administration of an active agent comprising at least one steroid, in the form of topical sprays that are...
2018/0207177 TREATMENT OF TRIPLE NEGATIVE BREAST CANCER UTILIZING ANDROST-5-ENE-3b,17b-DIOL (b-AED),...
A hormone modulator for causing cellular apoptosis in triple-negative breast cancer cells. The hormone modulator includes at least one of ...
2018/0207176 MULTIPHASIC CONTRACEPTIVE REGIMEN FOR ORAL COMBINATION DRUG FORMULATION OF PROGESTIN AND ESTROGEN
A method for contraception includes administering to a female daily, during a time period of 21 successive days, an oral combination drug formulation of...
2018/0207175 COMPOSITION FOR LOWERING INTRAOCULAR PRESSURE
A tears-resistant and enduring intraocular pressure lowing composition comprises an intraocular pressure lowering drug, a mucoadhesive polymer, a PH sensitive...
2018/0207174 Hypotensive lipid-containing biodegradable intraocular implants and related methods
Biocompatible intraocular implants include a prostamide component and a biodegradable polymer that is effective in facilitating release of the prostamide...
2018/0207173 ADMINISTRATION OF AURORA KINASE INHIBITOR AND CHEMOTHERAPEUTIC AGENTS
Disclosed are methods for the treatment of cancer in patients in need of such treatment. The methods comprise administering to such a patient an Aurora kinase...
2018/0207172 TREATMENT FOR VITILIGO
A method of treating vitiligo, including prophylaxis, in a subject in need thereof, comprising administering to said subject a pharmaceutically effective...
2018/0207171 SALT OF 3-[(3-{[4-(4-MORPHOLINYLMETHYL)-1H-PYRROL-2-YL]METHYLENE}-2-OXO-2,- ...
3-[(3-{[4-(4-morpholinylmethyl)-1H-pyrrol-2-yl]methylene}-2-oxo-2,3-dihyd- ro-1H-indol5-yl)methyl]-1,3-thiazolidine-2,4-dione methanesulphonate of formula...
2018/0207170 METHODS AND COMPOSITIONS USEFUL FOR TREATING DISEASES INVOLVING BCL-2 FAMILY PROTEINS WITH ISOQUINOLINE AND...
The present invention relates to a compositions for and methods for cancer treatment, for example, hematopoietic cancers (e.g. B-cell Lymphoma). In other...
2018/0207169 METHODS OF PREVENTING TOXICITY OF PLATINUM DRUGS
Methods for reducing platinum drug-induced toxicity in a cell expressing Organic Cation Transporter 2 (OCT2), methods for reducing platinum drug-induced...
2018/0207168 DACTINOMYCIN COMPOSITIONS AND METHODS FOR THE TREATMENT OF ACUTE MYELOID LEUKEMIA
The disclosure provides a method for treating NPM1-mutated acute myeloid leukemia (AML) by administration of a composition comprising dactinomycin.
2018/0207167 CALCINEURIN INHIBITORS OF THE SETRON FAMILY FOR THE TREATMENT OF HEARING LOSS
Disclosed is an inhibitor of calcineurin of the setron family for use for treating hearing loss in a subject in need thereof.
2018/0207166 Compounds and Compositions for Ossification and Methods Related Thereto
The disclosure relates to compounds and compositions for forming bone and methods related thereto. In one embodiment, the disclosure relates to a composition...
2018/0207165 METHODS AND COMPOSITIONS FOR STIMULATING BENEFICIAL BACTERIA IN THE GASTROINTESTINAL TRACT
The invention relates to supporting the growth or maintenance of oxygen-sensitive bacteria in the gastrointestinal tract of an animal. Provided is the use of...
2018/0207163 Methods and compositions for treating solid tumors and other malignancies
A combination of a CDK4/6 inhibitor and an mTOR inhibitor for the treatment of cancer.
2018/0207162 CRYSTALLINE FORM OF (S)-N-(5-((R)-2-(2,5-DIFLUOROPHENYL)-PYRROLIDIN-1-YL)-PYRAZOLO[1,5-A]PYRI- ...
A novel crystalline form of (S)--N-(5-((R)-2-(2,5-difluorophenyl)pyrrolidin-1-yl)-pyrazolo[1,5-a]pyri- midin-3-yl)-3-hydroxypyrrolidine-1-carboxamide,...
2018/0207161 POLYFLUORINATED COMPOUNDS ACTING AS BRUTON TYROSINE KINASE INHIBITORS
Described herein is a novel series of multi-fluoro-substituted pyrazolopyrimidine compounds or salts thereof. These compounds are Bruton's tyrosine kinase...
2018/0207160 THYMINE DERIVATIVES AND QUINAZOLINE-DIONE DERIVATIVES FOR THE INHIBITION OF HSP27
The present invention relates to novel HSP27 inhibitors, in particular thymine derivatives according to general formula (VI), (VII) or (VII) and phenothiazine...
2018/0207159 PYRAZOLOPYRIDAZINES AND METHODS FOR TREATING RETINAL-DEGENERATIVE DISEASES AND HEARING LOSS ASSOCIATED WITH...
Compounds, compositions and methods for the treatment of retinal degenerative diseases, such as retinitis pigmentosa, Leber's congenital Amaurosis, Syndromic...
2018/0207158 1-PYRAZOLYL-3-(4-((2-ANILINOPYRIMIDIN-4 -YL) OXY) NAPTHTHALEN-1 - YL) UREAS AS P38 MAP KNASE INHIBITORS
There are provided compounds of formula (I) which are inhibitors of the family of p38 mitogen-activated protein kinase enzymes, and to their use in therapy,...
2018/0207157 (4-((3R,4R)-3-METHOXYTETRAHYDRO-PYRAN-4-YLAMINO)PIPERIDIN-1-YL)(5-METHYL-6- ...
The invention provides a salt of a tetrahydropyranylmethylaminopyrimidine amide, such as the citrate salt of ...
2018/0207156 DIHYDROINDENE AND TETRAHYDRONAPHTHALENE COMPOUNDS
The invention provides compounds of formula I: ##STR00001## and salts thereof, as well as pharmaceutical compositions comprising such compounds. The compounds...
2018/0207155 PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF VIRAL INFECTIONS
This invention relates to pyrimidine derivatives, processes for their preparation, pharmaceutical compositions, and their use in treating viral infections such...
2018/0207154 Therapeutic Combinations of a BTK Inhibitor, a PI3K Inhibitor and/or a JAK-2 Inhibitor
Therapeutic combinations of a Janus kinase-2 (JAK-2) inhibitor, a Bruton's tyrosine kinase (BTK) inhibitor, and/or a phosphoinositide 3-kinase (PI3K)...
2018/0207153 UREA DERIVATIVE OR PHARMACOLOGICALLY ACCEPTABLE SALT THEREOF
The present invention provides a urea derivative or a pharmacologically acceptable salt thereof that has a formyl peptide receptor like 1 (hereinafter may be...
2018/0207152 ANTICOAGULANT REVERSAL AGENTS
Novel anticoagulant reversal compounds are disclosed, as well as methods of making the compounds, pharmaceutical compositions including the compounds, methods...
2018/0207151 BUPROPION AS A MODULATOR OF DRUG ACTIVITY
Dosage forms, drug delivery systems, and methods related to sustained release of dextromethorphan or improved therapeutic effects are disclosed. Typically,...
2018/0207150 COMPOUNDS AND ANTI-TUMOR NQO1 SUBSTRATES
Compositions comprising Formula (I) can be selectively lethal toward a variety of different cancer cell types. The compositions are useful for the management,...
2018/0207149 METHODS AND COMPOSITIONS FOR ENHANCING IMMUNE RESPONSE TO VACCINATION
Compositions and methods are described in which the topical application of a toll-like receptor 7 agonist or a toll-like receptor 9 agonist at or near a...
2018/0207148 THERAPEUTIC COMBINATIONS OF ORALLY ADMINISTERED PACLITAXEL AND A P-gp INHIBITOR FOR THE TREATMENT OF CANCER
The application pertains to pharmaceutical combinations of orally administered paclitaxel and a P-gp inhibitor. The pharmaceutical combinations are suitable...
2018/0207147 USE OF AMITRIPTYLINE FOR BLOCKING BRAIN HEMICHANNELS AND METHOD FOR POTENTIATING ITS EFFECT IN VIVO
The present invention relates to the use of amitriptyline as an inhibitor of connexin hemichannels (HC) in the Central Nervous System (CNS). This HC-blocking...
2018/0207146 PHARMACEUTICAL COMPOSITION COMPRISING 5ALPHA-REDUCTASE INHIBITOR
Disclosed is a composition comprising a 5.alpha.-reductase inhibitor. Forming a liquid crystal upon exposure to an aqueous fluid, the composition can release...
2018/0207145 PHARMACEUTICAL COMPOSITIONS COMPRISING DANIRIXIN FOR TREATING INFECTIOUS DISEASES
Provided are compounds and pharmaceutically acceptable salts thereof, and combinations of compounds, their pharmaceutical compositions, their methods of...
2018/0207144 ENHANCER OF ZESTE HOMOLOG 2 INHIBITORS
This invention relates to novel substituted benzamide according to Formula (I) which are inhibitors of Enhancer of Zeste Homolog 2 (EZH2), to pharmaceutical...
2018/0207143 Aqueous Suspensions Of Oximes For Autoinjectors
The present invention is directed at aqueous suspensions of oxime compounds, such as 2-pyridine aldoxime methyl chloride (2-PAM Cl) for autoinjectors. The...
2018/0207142 AVIBACTAM AND CARBAPENEMS ANTIBACTERIAL AGENTS
Described are methods of treating or preventing a bacterial infection by administering an antibacterial agent comprising a .beta.-lactamase inhibitor and one...
2018/0207141 3-(1H-PYRROLO[2,3-B]PYRIDIN-2-YL)-1H-INDAZOLES AND THERAPEUTIC USES THEREOF
Indazole compounds for treating various diseases and pathologies are disclosed. More particularly, the present disclosure concerns the use of an indazole...
2018/0207140 Pyrazolopyrimidines as Inhibitors of Glucocorticoid Receptor Translocation
Provided herein are compounds and pharmaceutical compositions comprising said compounds. The subject compounds and compositions are useful as modulators of...
2018/0207139 IMMEDIATE RELEASE PHARMACEUTICAL COMPOSITION OF TIZANIDINE
The present invention relates to an immediate release solid oral pharmaceutical composition comprising an effective amount of Tizanidine or its...
2018/0207138 METHODS FOR THE TREATMENT OF TREMORS BY POSITIVE MODULATION OF SK CHANNELS
Provided herein is the use of one or more small-conductance calcium-activated potassium channel positive modulators (SK positive modulators) for the treatment...
2018/0207137 2-ARYL- AND 2-ARYLALKYL-BENZIMIDAZOLES AS MIDH1 INHIBITORS
The present invention relates to 2-Aryl- and 2-Arylalkyl-benzimidazoles of general formula (I): in which A, R.sup.1, R.sup.4, R.sup.5, R.sup.6, R.sup.7,...
2018/0207136 OPHTHALMIC PHARMACEUTICAL COMPOSITIONS AND USES RELATING THERETO
The disclosure relates to ophthalmic pharmaceutical compositions comprising pilocarpine or a pharmaceutically acceptable salt. Aspects of the disclosure...
2018/0207135 OXYMETAZOLINE FOR THE TREATMENT OF ANO-RECTAL DISORDERS
Methods for treating fecal incontinence by administering to a subject in need thereof compositions including oxymetazoline as an active ingredient. Kits...
2018/0207134 COMPOSITION FOR THE INCREASE OF HUMORAL SECRETION
The present invention concerns compositions for the increase in the humoral secretion comprising imidazole peptides or extracts containing them, as well as the...
2018/0207133 ANESTHETIC COMPOSITIONS AND METHODS COMPRISING IMIDAZOLINE COMPOUNDS
Effective implantable medical devices and methods for reducing and treating acute pain by providing local anesthesia and nerve blockade using an imidazoline...
2018/0207132 SPIROCYCLIC COMPOUNDS
Disclosed herein are spirocyclic compounds, together with pharmaceutical compositions and methods of ameliorating and/or treating a cancer described herein...
2018/0207131 PLASTIC CONTAINER COMPRISING CYCLIC POLYOLEFIN LAYER
The present invention provides and a plastic container and multilayered films, which comprises a heat-sealable seal layer, a cyclic polyolefin layer, and an...
← Previous | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 | Next →

File A Patent Application

  • Protect your idea -- Don't let someone else file first. Learn more.

  • 3 Easy Steps -- Complete Form, application Review, and File. See our process.

  • Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.